RECITALS:Stock Purchase Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • New York
Contract Type FiledNovember 8th, 2005 Company Jurisdiction
WITNESSETH:License Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 8th, 2006 Company Industry
EXHIBIT 10.24 THIS AGREEMENT made in duplicate as of the 22 day of March, 2006, BETWEEN: MDS NORDION, a division of MDS (Canada) Inc. a corporation incorporated under the laws of Canada having a place of business at 447 March Road, Kanata, Ontario,...Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
Contract Type FiledDecember 8th, 2006 Company Industry Jurisdiction
RECITALS:Securities Purchase Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 1st, 2007 Company Industry Jurisdiction
EXHIBIT 10.27 LICENSE AGREEMENTLicense Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Basel-Stadt
Contract Type FiledDecember 8th, 2006 Company Industry Jurisdiction
DEFINITIONSLicense Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
Contract Type FiledDecember 8th, 2006 Company Industry Jurisdiction
RECITALS:Registration Rights Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • New York
Contract Type FiledNovember 8th, 2005 Company Jurisdiction
WITNESSETH:Employment Agreement • April 2nd, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledApril 2nd, 2007 Company Industry Jurisdiction
RECITALS:Investor Rights Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • New York
Contract Type FiledNovember 8th, 2005 Company Jurisdiction
RECITALS:Registration Rights Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 1st, 2007 Company Industry Jurisdiction
Exhibit 10.34 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 to the Employment Agreement is made as of the 14th day of November, 2005 by and among Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the "Employer"), and...Employment Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 1st, 2007 Company Industry
Exhibit 10.3 AMENDED AND RESTATED VOTING AGREEMENT THIS AMENDED AND RESTATED VOTING AGREEMENT is dated as of March 29, 2005 by and among Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the "Company"), the holders of the Company's...Voting Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • Massachusetts
Contract Type FiledNovember 8th, 2005 Company Jurisdiction
First AmendmentLicense Agreement • January 30th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 30th, 2007 Company Industry
MDS NORDION, a division of MDS (Canada) Inc. having a place of business at 447 March Road Ottawa, Ontario, Canada K2K1X8 ("Nordion")Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
Contract Type FiledDecember 8th, 2006 Company Industry Jurisdiction
Exhibit 10.36 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 to the Employment Agreement is made as of the 14th day of November, 2005 by and among Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the "Employer"), and...Employment Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 1st, 2007 Company Industry
Exhibit 10.37 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 to the Employment Agreement is made as of the 14th day of November, 2005 by and among Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the "Employer"), and...Employment Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 1st, 2007 Company Industry
EXHIBIT 10.30 TECHNOLOGY TRANSFER AGREEMENT THIS TECHNOLOGY TRANSFER AGREEMENT (the "Agreement") is entered into effective as of the 20th day of December 2006 (the "Effective Date"), by and between Mallinckrodt Inc., a Delaware corporation, with a...Technology Transfer Agreement • January 30th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 30th, 2007 Company Industry Jurisdiction
1. BACKGROUNDExclusive License Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • District of Columbia
Contract Type FiledNovember 8th, 2005 Company Jurisdiction
WITNESSETH:Employment Agreement • January 19th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledJanuary 19th, 2006 Company Industry Jurisdiction
Common StockMolecular Insight Pharmaceuticals, Inc. • January 25th, 2007 • Pharmaceutical preparations • New York
Company FiledJanuary 25th, 2007 Industry Jurisdiction
WITNESSETH:Employment Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • Massachusetts
Contract Type FiledNovember 8th, 2005 Company Jurisdiction
BACKGROUNDLicense, Development and Commercialization Agreement • January 30th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 30th, 2007 Company Industry Jurisdiction
RECITALS:Contract of Purchase and Sale • May 17th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledMay 17th, 2007 Company Industry Jurisdiction
INVESTMENT AGREEMENT dated as of December 9, 2010 between MOLECULAR INSIGHT PHARMACEUTICALS, INC. and SAVITR CAPITAL LLCInvestment Agreement • December 14th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 14th, 2010 Company Industry JurisdictionTHIS INVESTMENT AGREEMENT (together with all exhibits and schedules hereto and as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms hereof, the “Agreement”), dated as of December 9, 2010, by and among Savitr Capital LLC, a Delaware limited liability company (the “Investor”) and Molecular Insight Pharmaceuticals, a Massachusetts corporation (the “Company”) and its successors, including, as the context may require, on or after the Effective Date, as reorganized pursuant to the Bankruptcy Code.
CHANGE OF CONTROL AGREEMENTChange of Control Agreement • March 26th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 26th, 2010 Company Industry JurisdictionThis CHANGE OF CONTROL AGREEMENT, made as of March 22, 2010, is by and between Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the “Company”), and Charles H. Abdalian, Jr. (the “Employee”). All references to the Company include all affiliated or subsidiary entities including, without limitation, a Buyer in a Change of Control (each as defined below).
SECURITY AGREEMENTSecurity Agreement • May 4th, 2011 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 4th, 2011 Company Industry JurisdictionSECURITY AGREEMENT, dated as of April 28, 2011, made by Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the “Grantor”), in favor of NexBank SSB, a Texas-chartered savings bank (“NexBank”), as collateral agent (in such capacity, together with its successors and assigns in such capacity, the “Collateral Agent”) acting pursuant to this Agreement for the benefit of the Secured Parties (as defined in the Credit Agreement referred to below).
andUnit Purchase Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • Massachusetts
Contract Type FiledNovember 8th, 2005 Company Jurisdiction
TEN COM - as tenants in common UNIF GIFT MIN ACT- ____________ Custodian ____________ TEN ENT - as tenants by the (Cust) (Minor) entireties JT TEN - as joint tenants with under Uniform Gifts to Minors right of survivorship Act ________________ and not...Molecular Insight Pharmaceuticals, Inc. • January 22nd, 2007 • Pharmaceutical preparations
Company FiledJanuary 22nd, 2007 Industrytransferable on the books of the Corporation by the holder hereof in person or by duly authorized Attorney, upon surrender of this Certificate, properly endorsed. This Certificate and the shares represented hereby are issued under and shall be held subject to the laws of the Commonwealth of Massachusetts and the Articles of Organization and By-Laws of the Corporation and all amendments thereto, copies of which are on file with the Transfer Agent, to all of which the holder of this Certificate assents by acceptance hereof.
GREENWORKS MOLECULAR INSIGHT PHARMACEUTICALS LEASEGreenworks Molecular • May 8th, 2008 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMay 8th, 2008 Company Industry
SEVENTH AMENDMENT TO MOLECULAR INSIGHT PHARMACEUTICALS, INC., GREENWORKS LEASEMolecular Insight Pharmaceuticals, Inc. • January 25th, 2008 • Pharmaceutical preparations
Company FiledJanuary 25th, 2008 IndustryFor good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, RayJoe Limited Partnership (“Landlord”) and Molecular InSight Pharmaceuticals, Inc., (“Tenant”), confirm the following facts and their agreement as follows:
EMPLOYMENT AGREEMENT (for Donald Wallroth)Employment Agreement • September 11th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledSeptember 11th, 2007 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”), effective as of August 13, 2007 (the “Effective Date”), is made by and between Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation having its principal place of business at 160 Second Street, Cambridge, Massachusetts 02142 (the “Employer”), and Donald Wallroth (the “Employee”).
LEASE AGREEMENTLease Agreement • May 8th, 2008 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMay 8th, 2008 Company IndustryTHIS LEASE AGREEMENT (the “Lease”) is dated as of April 25, 2008, between ARE-MA REGION NO. 35, LLC, a Delaware limited liability company (“Landlord”), and MOLECULAR INSIGHT PHARMACEUTICALS, INC., a Massachusetts corporation (“Tenant”).
SECOND AMENDMENT TO LEASELease • May 6th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMay 6th, 2010 Company IndustryThis Second Amendment to Lease (the “Second Amendment”) is made as of March 30, 2010, by and between ARE-MA REGION NO. 35, LLC, a Delaware limited liability company, having an address at 385 East Colorado Boulevard, Suite 299, Pasadena, CA 91101 (“Landlord”), and MOLECULAR INSIGHT PHARMACEUTICALS, INC., a Massachusetts corporation, having an address at 160 Second Street, Cambridge, MA 02142 (“Tenant”).
Exhibit 10.20 MOLECULAR INSIGHT PHARMACEUTICALS CONSULTING AGREEMENT 1. INTRODUCTION. This Agreement is made by and between William C. Eckelman, Ph.D., ("Consultant"), with offices at 10432 Snow Point Drive, Bethesda, MD 20814, and Molecular Insight...Consulting Agreement • January 19th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledJanuary 19th, 2006 Company Industry Jurisdiction
PLEDGE AND SECURITY AGREEMENT dated as of November 16, 2007 Among THE ENTITIES LISTED ON SCHEDULE A HERETO, as Pledgors and THE BANK OF NEW YORK TRUST COMPANY, N.A., as Collateral AgentPledge and Security Agreement • November 16th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2007 Company IndustryIn consideration of the purchase of the Bonds (as hereinafter defined) issued under the Indenture by and among Molecular Insight Pharmaceuticals, Inc. and The Bank of New York Trust Company, N.A., as Trustee, Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation and each of the Subsidiary Guarantors party from time to time thereto (each a “Pledgor” and collectively the “Pledgors”) hereby agree with The Bank of New York Trust Company, N.A., as Collateral Agent, as follows (with certain terms used herein being defined in Article 7):